ULTRAGENYX PHARMACEUTICAL, INC.
Lobbying client. Federal LDA filings.
Connected on the graph
Inbound (32)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Joseph Edward Brown Iii | lobbied_for | — | lda_lobbyist_client | |
| — | Paul Thornell | lobbied_for | — | lda_lobbyist_client | |
| — | Natalie Mcintyre | lobbied_for | — | lda_lobbyist_client | |
| — | Lisa Kahlman | lobbied_for | — | lda_lobbyist_client | |
| — | Lisa Goldman | lobbied_for | — | lda_lobbyist_client | |
| — | Stephen M. Cote | lobbied_for | — | lda_lobbyist_client | |
| — | Earl Scott Flood | lobbied_for | — | lda_lobbyist_client | |
| — | Ashley Gunn | lobbied_for | — | lda_lobbyist_client | |
| — | Lauren Aronson | lobbied_for | — | lda_lobbyist_client | |
| — | Jon Adame | lobbied_for | — | lda_lobbyist_client | |
| — | David R Thomas | lobbied_for | — | lda_lobbyist_client | |
| — | Erica Jay Chabot | lobbied_for | — | lda_lobbyist_client | |
| — | Rosemary Gutierrez | lobbied_for | — | lda_lobbyist_client | |
| — | Alyene Mlinar | lobbied_for | — | lda_lobbyist_client | |
| — | Alexander Perkins | lobbied_for | — | lda_lobbyist_client | |
| — | Sage Eastman | lobbied_for | — | lda_lobbyist_client | |
| — | Annie Wolf | lobbied_for | — | lda_lobbyist_client | |
| — | Helen Tolar | lobbied_for | — | lda_lobbyist_client | |
| — | Michael Robinson | lobbied_for | — | lda_lobbyist_client | |
| — | Nichole Distefano | lobbied_for | — | lda_lobbyist_client | |
| — | Dean Rosen | lobbied_for | — | lda_lobbyist_client | |
| — | Jeffrey Miller | lobbied_for | — | lda_lobbyist_client | |
| — | Naveen Parmar | lobbied_for | — | lda_lobbyist_client | |
| — | Barrett Thornhill | lobbied_for | — | lda_lobbyist_client | |
| — | Elise Finley Pickering | lobbied_for | — | lda_lobbyist_client | |
| — | Bruce Mehlman | lobbied_for | — | lda_lobbyist_client | |
| — | Caitlin Van Sant | lobbied_for | — | lda_lobbyist_client | |
| — | Zachary Mallove | lobbied_for | — | lda_lobbyist_client | |
| 2026-01-01 | MILLER STRATEGIES, LLC | lobbies_for | — | lda_filing | |
| 2026-01-01 | MEHLMAN CONSULTING, INC. | lobbies_for | $60,000 | lda_filing | |
| 2026-01-01 | ULTRAGENYX PHARMACEUTICAL INC. | lobbies_for | $440,000 | lda_filing | |
| 2026-01-01 | FORBES-TATE | lobbies_for | — | lda_filing |
Outbound (2)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1262 — Mikaela Naylon Give Kids a Chance Act | — | H.R.1262 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 932 — Give Kids a Chance Act of 2025 | — | S. 932 | lobbying_bill_mention |
- Source id
60882- General description
- Biopharmaceutical Company
- State
- CA
- Country
- US
- Principal place of business
- US
- Effective date
- 2024-07-01
- Total spend (across 1 ingested filings)
- $60,000
Filings
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-17 | Q1 | 2026 | MEHLMAN CONSULTING, INC. | $60,000 |